157 related articles for article (PubMed ID: 32463435)
21. Impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in children under 5 years of age in the Czech Republic.
Kozakova J; Krizova P; Maly M
PLoS One; 2021; 16(2):e0247862. PubMed ID: 33635933
[TBL] [Abstract][Full Text] [Related]
22. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.
Yildirim I; Shea KM; Little BA; Silverio AL; Pelton SI;
Pediatrics; 2015 Mar; 135(3):495-503. PubMed ID: 25647674
[TBL] [Abstract][Full Text] [Related]
23. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades.
Harboe ZB; Benfield TL; Valentiner-Branth P; Hjuler T; Lambertsen L; Kaltoft M; Krogfelt K; Slotved HC; Christensen JJ; Konradsen HB
Clin Infect Dis; 2010 Feb; 50(3):329-37. PubMed ID: 20047478
[TBL] [Abstract][Full Text] [Related]
24. Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009-2014.
Chowers M; Regev-Yochay G; Mor O; Cohen-Poradosu R; Riesenberg K; Zimhony O; Chemtob D; Stein M; Dagan R; Levy I
Hum Vaccin Immunother; 2017 Jan; 13(1):216-219. PubMed ID: 27648488
[TBL] [Abstract][Full Text] [Related]
25. Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.
Rinta-Kokko H; Palmu AA; Auranen K; Nuorti JP; Toropainen M; Siira L; Virtanen MJ; Nohynek H; Jokinen J
Vaccine; 2018 Apr; 36(15):1934-1940. PubMed ID: 29526371
[TBL] [Abstract][Full Text] [Related]
26. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors.
Backhaus E; Berg S; Andersson R; Ockborn G; Malmström P; Dahl M; Nasic S; Trollfors B
BMC Infect Dis; 2016 Aug; 16():367. PubMed ID: 27487784
[TBL] [Abstract][Full Text] [Related]
28. Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study.
Vadlamudi NK; Patrick DM; Hoang L; Sadarangani M; Marra F
PLoS One; 2020; 15(9):e0239848. PubMed ID: 32997698
[TBL] [Abstract][Full Text] [Related]
29. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW
Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165
[TBL] [Abstract][Full Text] [Related]
30. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.
Lehmann D; Willis J; Moore HC; Giele C; Murphy D; Keil AD; Harrison C; Bayley K; Watson M; Richmond P
Clin Infect Dis; 2010 Jun; 50(11):1477-86. PubMed ID: 20420501
[TBL] [Abstract][Full Text] [Related]
31. Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine.
Wei SH; Chiang CS; Chiu CH; Chou P; Lin TY
Pediatr Infect Dis J; 2015 Mar; 34(3):e71-7. PubMed ID: 25247584
[TBL] [Abstract][Full Text] [Related]
32. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.
Rudnick W; Liu Z; Shigayeva A; Low DE; Green K; Plevneshi A; Devlin R; Downey J; Katz K; Kitai I; Krajden S; Ostrowska K; Richardson D; Richardson S; Sarabia A; Silverman M; Simor AE; Tyrrell G; McGeer A;
Vaccine; 2013 Dec; 31(49):5863-71. PubMed ID: 24099873
[TBL] [Abstract][Full Text] [Related]
33. Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease.
Palmu AA; Kilpi TM; Rinta-Kokko H; Nohynek H; Toropainen M; Nuorti JP; Jokinen J
Pediatrics; 2015 Jul; 136(1):e22-7. PubMed ID: 26077477
[TBL] [Abstract][Full Text] [Related]
34. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
[TBL] [Abstract][Full Text] [Related]
35. Invasive pneumococcal disease in HIV-infected adults: clinical changes after the introduction of the pneumococcal conjugate vaccine in children.
Burgos J; Peñaranda M; Payeras A; Villoslada A; Curran A; Garau M; Riera M; Crespo M; Navarro J; Van den Eynde E; Planes AM; Ribera E; Pahissa A; Falcó V
J Acquir Immune Defic Syndr; 2012 Jan; 59(1):31-8. PubMed ID: 22156821
[TBL] [Abstract][Full Text] [Related]
36. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States.
Rosen JB; Thomas AR; Lexau CA; Reingold A; Hadler JL; Harrison LH; Bennett NM; Schaffner W; Farley MM; Beall BW; Moore MR;
Clin Infect Dis; 2011 Jul; 53(2):137-43. PubMed ID: 21690620
[TBL] [Abstract][Full Text] [Related]
37. Burden of invasive pneumococcal disease (IPD) over a 10-year period in Bogotá, Colombia.
Severiche-Bueno DF; Severiche-Bueno DF; Bastidas A; Caceres EL; Silva E; Lozada J; Gomez S; Vargas H; Viasus D; Reyes LF
Int J Infect Dis; 2021 Apr; 105():32-39. PubMed ID: 33582374
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study.
Chan T; Tay MZ; Kyaw WM; Chow A; Ho HJ
BMC Infect Dis; 2020 Jun; 20(1):423. PubMed ID: 32552726
[TBL] [Abstract][Full Text] [Related]
39. Pneumococcal vaccination in people living with HIV.
Thornhill J; Sivaramakrishnan A; Orkin C
Vaccine; 2015 Jun; 33(28):3159-60. PubMed ID: 25128803
[TBL] [Abstract][Full Text] [Related]
40. Pneumococcal disease in South Australia: vaccine success but no time for complacency.
Johnson DR; D'Onise K; Holland RA; Raupach JC; Koehler AP
Vaccine; 2012 Mar; 30(12):2206-11. PubMed ID: 22273663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
